About Coriell Life Sciences
Coriell Life Sciences is a company based in Camden (United States) founded in 2013 was acquired by InformedDNA in March 2025. Coriell Life Sciences has raised $10.07 million across 2 funding rounds from investors including InformedDNA. Coriell Life Sciences offers products and services including Corigen and Research Analysis. Coriell Life Sciences operates in a competitive market with competitors including Omega Therapeutics, BAMF Health, InpharmD, BiomeSense and LifeOmic, among others.
- Headquarter Camden, United States
- SectorsHealthcare
- Website coriell.com
- Social LinkedIn X YouTube
- Acquired by InformedDNA (Mar 2025)
- Total Equity Funding$10.07M (USD)
in 2 rounds
- Latest Funding Round$9.47M (USD), Series A
May 2019
- Investors
- Acquired byInformedDNA
(Mar 2025)
Products & Services of Coriell Life Sciences
Coriell Life Sciences offers a comprehensive portfolio of products and services, including Corigen and Research Analysis.
Improves medication efficacy through DNA testing and reduces healthcare costs.
Offers analysis for conditions like women's health and infections via genetic methods.
Funding Insights of Coriell Life Sciences
Coriell Life Sciences has successfully raised a total of $10.07M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $9.47 million completed in May 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $10.07M
- Total Rounds 2
- Last Round Series A β $9.47M
- First Round $605,000
(Jul 2016)
All 2 funding rounds of Coriell Life Sciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2019 | $9.47M | Series A | β | β | β |
| Jul 2016 | $605,000 | Seed | β | β | β |
1 investors in total: 1 institutional.
Investors in Coriell Life Sciences
Coriell Life Sciences has secured backing from 1 investor. Prominent investors backing the company include InformedDNA.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Network of genetics experts provided to assist patients and providers. | 2007 | informeddna.com | St Petersburg, United States |
Investor details for Coriell Life Sciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Coriell Life Sciences
1 people are tracked at Coriell Life Sciences (1 in leadership).
| Name | Role | Group |
|---|---|---|
Bill Testa | Chief Financial Officer | Leadership |
Complete people profiles for Coriell Life Sciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Coriell Life Sciences
4 dated milestones of Coriell Life Sciences across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Coriell Life Sciences is founded.
- Funding First funding round of $605K.
- Funding Latest funding round, Series A, of $9.5M.
- Exit Acquired by InformedDNA.
Competitors of Coriell Life Sciences
Coriell Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Omega Therapeutics, BAMF Health, InpharmD, BiomeSense and LifeOmic, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| omegatherapeutics.com | 2016 | Cambridge, United States | $211M | 93 | Platform for human genome study is provided for precision medicine. | |
| bamfhealth.com | 2018 | Grand Rapids, United States | $4M | 25 | AI-enabled molecular imaging and theranostics for disease diagnostics are developed. | |
| inpharmd.com | 2014 | Atlanta, United States | $6.63M | – | Evidence-based drug information is provided to healthcare providers online. | |
| biomesense.com | 2018 | Chicago, United States | $8.43M | 9 | AI-enabled platform for microbiome data generation and analysis is developed. | |
| lifeomic.com | 2016 | Indianapolis, United States | – | 111 | Storage, management and analysis of omic data for health applications | |
| cuezen.com | 2021 | Seattle, United States | $5.2M | – | AI-powered personalization engine for health behavior change is provided. | |
| datma.com | 2016 | Beaverton, United States | $2.5M | – | Provider of software to clinics for decision-making and omics data automation | |
| 4dmedvision.com | 2017 | Hangzhou, China | – | – | AI and cloud-based precision diagnosis tools for healthcare are developed. | |
| wm-therapeutics.com | 2020 | Heidelberg, Germany | – | 12 | Small-molecule cancer therapeutics are developed to inhibit Warburg metabolism. |
Detailed competitors of Coriell Life Sciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Coriell Life Sciences
Complete news archive for Coriell Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Coriell Life Sciences
10 companies that operate in the same segment as Coriell Life Sciences (Clinical IT & Data Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of fitness memberships encompassing group classes, gyms, and at-home workouts | 2016 | Bengaluru, Karnataka, India | USD 713.57 M | – | – | |
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | – | – | |
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 233 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | – | – | |
Tech-enabled mental health solutions for employers are provided. | 2016 | New York, New York, United States | USD 508.73 M | – | – | |
App-based health insurance is offered to individuals and businesses. | 2016 | Paris, France | USD 863.12 M | – | – | |
Virtual care programs for managing chronic diseases are provided. | 2011 | San Francisco, California, United States | USD 450.12 M | USD 260.21 M | – | |
AI-driven EMR and practice management software is delivered for clinics. | 2010 | Boca Raton, Florida, United States | USD 329.17 M | – | – | |
Cloud-based administrative tools for healthcare providers are offered. | 1997 | Watertown, United States | USD 40 M | – | – | |
Membership-based primary care platform is offered for employees and consumers. | 2007 | San Francisco, California, United States | USD 402.56 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Coriell Life Sciences
Coriell Life Sciences was founded in 2013 and raised its 1st funding round 3 years after it was founded.
Coriell Life Sciences is headquartered in Camden, United States.
Coriell Life Sciences is a funded company, having raised a total of $10.07M across 2 funding rounds to date. The company's 1st funding round was a Seed of $605K, raised on Jul 2016.
Coriell Life Sciences was founded in 2013 in Camden, United States, within the precision medicine sector. Platform technologies are utilized by clinicians to order genomic sequencing, obtain expert interpretations, and maintain secure storage of genomic data. The flagship product, GeneDose, is applied to buccal swabs from patients to forecast drug pharmacokinetics, metabolism, and potential adverse effects. Therapeutic solutions are provided across pain management, cardiology, gastroenterology, neurology, psychiatry, and additional fields.
Coriell Life Sciences's top competitors include Omega Therapeutics, CueZen and BAMF Health.
Coriell Life Sciences offers Corigen and Research Analysis.
Coriell Life Sciences has 1 investor. Key investors include InformedDNA.
Yes. Coriell Life Sciences was acquired by InformedDNA in March 2025.